Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

New study examines the use of anticholinergic drug trihexyphenidyl for PTSD symptoms

Staff Writer
Staff Writer 2 years ago
Updated 2021/07/07 at 1:46 AM
Share
SHARE

A new study in Brain and Behavior provides a first glimpse at a potentially effective anticholinergic drug known as trihexyphenidyl (TP) for the treatment of symptoms of post-traumatic stress disorder (PTSD).

According to researchers with the Sogo PTSD Institute and the Medical Corporation Sogokai, trihexyphenidyl may be effective for reducing PTSD-related flashbacks and nightmares.

As part of the study, 34 patients diagnosed with PTSD were administered the anticholinergic drug, with the vast majority, or 88 percent of patients have experienced mild to no PTSD-based nightmares; while 79 percent experienced similar responses for flashbacks.

The anticholinergic effects reported had a rapid onset, with purported improvements in mild symptoms of nightmares and flashbacks associated with PTSD.

“This study is the first to demonstrate the potential efficacy of TP in the treatment of refractory PTSD-related nightmares and flashbacks,” the co-authors detailed in their journal report.

“Further double-blind, randomized control trials are needed to explore the potential clinical benefits of TP in PTSD.”

You Might Also Like

Study boasts MDMA-assisted therapy for PTSD patients

How the brain is organized is revealed by the largest genetic study of brain structure to date

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

New study reveals positive results from postpartum depression treatment Zuranolone

New study explores magic mushrooms for anorexia nervosa psychopathology

TAGGED: mental health, trihexyphenidyl, ptsd
Staff Writer July 6, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Tetrahydrocannabinol exposure during gestational period may affect response to fluoxetine
Next Article How air pollutants may raise the risk of menstrual cramps in women

Recommended

Clinical

Study boasts MDMA-assisted therapy for PTSD patients

1 Min Read
Clinical

How the brain is organized is revealed by the largest genetic study of brain structure to date

2 Min Read
Clinical

Study investigates the ethical implications of combining the analysis of ancient DNA and data from private genetic databases

3 Min Read
Clinical

New study reveals positive results from postpartum depression treatment Zuranolone

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?